Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2022 · 10-Q
Revenue$27.04M$27.04M+8.9% vs Q2 2021 Net Income-$164.00K-$164.00KN/M vs Q2 2021 EPS Diluted-$0.01-$0.01N/M vs Q2 2021 Gross Profit$14,901,000−1.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,417,000−12.1% Free Cash Flowderived$5,259,000−11.9% Margins · derivedGross margin55.1%−5.5 pt vs Q2 2021
Operating margin0.8%−2.0 pt vs Q2 2021
Net margin-0.6%−3.9 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 4, 2022 · 35 d after period end